132 related articles for article (PubMed ID: 33859674)
1. Elevated GAS2L3 Expression Correlates With Poor Prognosis in Patients With Glioma: A Study Based on Bioinformatics and Immunohistochemical Analysis.
Zhou Y; Zhang L; Song S; Xu L; Yan Y; Wu H; Tong X; Yan H
Front Genet; 2021; 12():649270. PubMed ID: 33859674
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis regarding the correlation between GAS2 family genes and human glioma prognosis.
Zhao C; Zhang N; Cui X; Zhang X; Ren Y; Su C; He J; Zhang W; Sun X; Yang J; Gao X
Cancer Med; 2021 Apr; 10(8):2826-2839. PubMed ID: 33713047
[TBL] [Abstract][Full Text] [Related]
3. GPR37 expression as a prognostic marker in gliomas: a bioinformatics-based analysis.
Liang K; Guo Z; Zhang S; Chen D; Zou R; Weng Y; Peng C; Xu Z; Zhang J; Liu X; Pang X; Ji Y; Liao D; Lai M; Peng H; Ke Y; Wang Z; Wang Y
Aging (Albany NY); 2023 Oct; 15(19):10146-10167. PubMed ID: 37837549
[TBL] [Abstract][Full Text] [Related]
4. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
5. CENPN Acts as a Novel Biomarker that Correlates With the Malignant Phenotypes of Glioma Cells.
Wu H; Zhou Y; Wu H; Xu L; Yan Y; Tong X; Yan H
Front Genet; 2021; 12():732376. PubMed ID: 34646306
[No Abstract] [Full Text] [Related]
6. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
7. Gas2l3 is essential for brain morphogenesis and development.
Sharaby Y; Lahmi R; Amar O; Elbaz I; Lerer-Goldshtein T; Weiss AM; Appelbaum L; Tzur A
Dev Biol; 2014 Oct; 394(2):305-13. PubMed ID: 25131197
[TBL] [Abstract][Full Text] [Related]
8. Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas.
Luo C; Liu Z; Ye W; Liu F
Front Cell Dev Biol; 2021; 9():756005. PubMed ID: 34805164
[No Abstract] [Full Text] [Related]
9. Deletion of Gas2l3 in mice leads to specific defects in cardiomyocyte cytokinesis during development.
Stopp S; Gründl M; Fackler M; Malkmus J; Leone M; Naumann R; Frantz S; Wolf E; von Eyss B; Engel FB; Gaubatz S
Proc Natl Acad Sci U S A; 2017 Jul; 114(30):8029-8034. PubMed ID: 28698371
[TBL] [Abstract][Full Text] [Related]
10. High expression of COPB2 predicts adverse outcomes: A potential therapeutic target for glioma.
Zhou Y; Wang X; Huang X; Li XD; Cheng K; Yu H; Zhou YJ; Lv P; Jiang XB
CNS Neurosci Ther; 2020 Mar; 26(3):309-318. PubMed ID: 31710183
[TBL] [Abstract][Full Text] [Related]
11. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A
Front Genet; 2021; 12():718717. PubMed ID: 34925438
[No Abstract] [Full Text] [Related]
12. CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas.
Xu S; Li X; Tang L; Liu Z; Yang K; Cheng Q
Front Mol Biosci; 2021; 8():706949. PubMed ID: 34540893
[No Abstract] [Full Text] [Related]
13. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
Hu Y; Tu Z; Lei K; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
15. High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma.
Xiong Y; Li M; Bai J; Sheng Y; Zhang Y
Front Oncol; 2021; 11():650534. PubMed ID: 33996568
[TBL] [Abstract][Full Text] [Related]
16. PCGF1 is a prognostic biomarker and correlates with tumor immunity in gliomas.
Xie J; Qiao L; Deng G; Liang N; Xing L; Zhang J
Ann Transl Med; 2022 Feb; 10(4):227. PubMed ID: 35280367
[TBL] [Abstract][Full Text] [Related]
17. Arachidonate lipoxygenases 5 is a novel prognostic biomarker and correlates with high tumor immune infiltration in low-grade glioma.
Pan RH; Zhang X; Chen ZP; Liu YJ
Front Genet; 2023; 14():1027690. PubMed ID: 36777735
[No Abstract] [Full Text] [Related]
18.
Qu S; Liu J; Wang H
Front Immunol; 2021; 12():648416. PubMed ID: 33889156
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of Inflammatory Response-Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma.
Han T; Zuo Z; Qu M; Zhou Y; Li Q; Wang H
Front Pharmacol; 2021; 12():748993. PubMed ID: 34712139
[No Abstract] [Full Text] [Related]
20. A Prognostic Microenvironment-Related Immune Signature
Qiu H; Li Y; Cheng S; Li J; He C; Li J
Front Oncol; 2020; 10():580263. PubMed ID: 33425732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
